|
|||||
Two biotechnology enterprises developing cancer treatments are pooling their efforts to develop therapies aimed at more specific targets across a range of solid tumor types. . . . → Read More: Biotechs Collaborate on More Precise Gene, Cell Cancer Therapies  2 comments - (Comments are closed)  Finance, Joint ventures/collaborations  biomedical, biotechnology, cancer, equity, investment, life sciences, mathematics, pharmaceuticals, physical sciences 
A compound designed to help cancer therapies better penetrate and kill solid tumors is being tested in its first clinical trial among patients with pancreatic cancer. . . . → Read More: Trial Testing Cancer Treatment Delivery Compound One comment - (Comments are closed) New products Australia, biomedical, biotechnology, cancer, clinical trials, entrepreneurs, life sciences, pharmaceuticals 
Researchers in Italy and the U.S. found a potential source of new antibiotics in derivatives of peptides used by the digestive process in the stomach. . . . → Read More: New Antibiotics Discovered in Stomach Peptides Comments are closed New products biomedical, biotechnology, engineering, Europe, life sciences, mathematics, pharmaceuticals, physical sciences, preclinical, university 
An international collaboration published a complete, annotated genomic sequencing of wheat used in making bread, a widely grown staple crop and major source of nutrition worldwide. . . . → Read More: Bread Wheat Genome Sequenced Comments are closed Joint ventures/collaborations, New products agriculture, biotechnology, genomics, life sciences, university 
A biotechnology company in Germany and drug maker Pfizer are developing a vaccine to prevent seasonal influenza using messenger RNA that instructs cells on production of proteins. . . . → Read More: Pfizer, Biotech Partner on RNA Flu Vaccine 2 comments - (Comments are closed) Intellectual property, Joint ventures/collaborations biomedical, biotechnology, equity, Europe, investment, licensing, life sciences, pharmaceuticals 
Pain drugs made from peptides, small protein-like compounds, and guided by antibodies are being developed as alternatives to prescription opioids to treat moderate to severe pain. . . . → Read More: Peptide Pain Drugs in Development Aimed at Alternative Targets One comment - (Comments are closed) New products biomedical, biotechnology, grant, life sciences, NIH, pharmaceuticals, preclinical 
A treatment that silences the actions of RNA and reverses damage to nerves from a rare inherited neurological disease was approved by the Food and Drug Administration. . . . → Read More: FDA Approves RNA-Interference Nerve Disease Therapy 2 comments - (Comments are closed) Regulations biomedical, biotechnology, clinical trials, FDA, genomics, life sciences, nanotechnology, pharmaceuticals 
A new research project is investigating components in raw cow’s milk that could make it possible to give chemotherapy for cancer as oral drugs rather than infusions. . . . → Read More: Cancer Drug Delivery Through Milk Particles Under Study 2 comments - (Comments are closed) Finance, New products agriculture, biomedical, biotechnology, cancer, grant, life sciences, NIH, pharmaceuticals, preclinical, university 
A new enterprise founded by scientists, is underway developing treatments for advanced liver disorders that combine new drugs with cell and gene therapies to restore or replace liver functions. . . . → Read More: Start-Up Developing Regenerative Liver Disease Treatments Comments are closed Finance, Intellectual property biomedical, biotechnology, chemistry, entrepreneurs, equity, investment, licensing, life sciences, pharmaceuticals, physical sciences, stem cells, university, venture capital 
Drug maker Allergan is acquiring the rights from Editas Medicine to develop an application of the genome-editing technology Crispr for the inherited eye disease Leber congenital amaurosis type 10. . . . → Read More: Allergan Licensing Crispr for Inherited Eye Disease One comment - (Comments are closed) Intellectual property, Joint ventures/collaborations biomedical, biotechnology, genomics, licensing, life sciences, pharmaceuticals |
One Blood Test Fits All Diseases A Thinking Person’s Artificial Intelligence Do You Want Your Bacon CRISPR? Health Care, Precisely One Person at a Time Let Guinea Pigs be Guinea Pigs Look Out Pharma. The Tech Industry is After You |
||||
|
Copyright © 2018 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
